SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Rho offers support for NIH trial on peanut allergies

CRO (Contract Research Organization) Rho collaborated with the NIH (National Institutes of Health) on its most recent study that found a major reduction of peanut allergies in children who began early, continuous consumption of peanuts.

Peanuts: deadly to some, delicious to others and profitable to Rho

Cromos launches cardiology-based site research organization in Russia

Moscow-based Cromos Pharma, an international full-service CRO, has launched Cardiorus, a cardiology and cardiothoracic surgery site research organization (SRO), with its clinical base being at the Bakoulev Center of Cardiovascular Surgery in Moscow.

Valeant sacks Dendreon admin staff and plans manufacturing savings

Valeant has started cutting jobs at Provenge manufacturer Dendreon just over a week after it acquired the bankrupt firm for $495m.

CMO group wants US FDA fees to be exempt from enforced budget cuts

A US CMO industry group has backed plans to exempt privately paid user fees from Government spending cuts enforced if US politicians fail to agree a budget.

Senators reintroduce bill to offer CROs a share of R&D tax credit

Sens. Tom Carper (D-Del.) and Pat Toomey (R-Penn.) reintroduced a bill that would permanently allow CROs (contract research organizations) to capture a share of the R&D tax credit. 

Spotlight

Researchers enthusiastic over Obama’s new $215m precision medicine initiative

Researchers enthusiastic over Obama’s new $215m precision medicine initiative

In what was largely a pep rally for science, President Obama on Friday unveiled his $215m precision...

Parexel sees book-to-bill bounce back as GSK strategic partnership renewal bears fruit

Parexel sees book-to-bill bounce back as GSK strategic partnership renewal bears fruit

One quarter after announcing a disappointing book-to-bill ratio, CRO Parexel has now renewed its strategic partnership with...

AstraZeneca turns to CRISPR for drug discovery; Are you watching Cellectis?

AstraZeneca turns to CRISPR for drug discovery; Are you watching Cellectis?

AstraZeneca has partnered to use the CRISPR genome editing technique across its discovery programmes in a move...

HCV drugs Sovaldi and Olysio boost Q1 sales for AmeriSourceBergen

HCV drugs Sovaldi and Olysio boost Q1 sales for AmeriSourceBergen

New hepatitis C drugs produced by Gilead, Janssen and AbbVie contributed to a first quarter spike in...

Strong USD to hit revenues but strategic CROs may see lower costs

Strong US Dollar to hit revenues but strategic CROs may see lower costs

The strengthening US Dollar will reduce CRO revenues, say analysts, but firms which have global strategic deals...

Biosimulation – the next step in PK modelling embraced by regulators

Biosimulation – the next step in PK modelling embraced by regulators

Computer-based drug modelling is moving from a discovery aid to a clinical tool accepted by regulators, according...